Principles of therapy



The overriding principle behind the treatment of depression is to optimize treatment on an individual basis in order to meet the needs of the patient and to obtain the best possible clinical outcome. This involves not only careful assessment and application of the best evidence by the doctor or therapist but also sensitivity to the wishes, concerns, and beliefs of the patient. To be successful, treatment should be a mutual enterprise based on negotiation that recognizes the different roles of therapist and patient, and the patient’s rights to make informed choices.


Psychological Treatment Seasonal Affective Disorder Bright Light Therapy Mental Health Legislation Specific Treatment Option 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Zimmerman M, McGlinchey JB, Posternak MA, et al. How should remission from depression be defined? The depressed patient’s perspective. Am J Psychiatry 2006; 163:148–150.PubMedCrossRefGoogle Scholar
  2. 2.
    Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370:851–858.PubMedCrossRefGoogle Scholar
  3. 3.
    Judd LL, Akiskal HS, Maser JD, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55:694–700.PubMedCrossRefGoogle Scholar
  4. 4.
    Lam RW, Michalak EE, Swinson RP. Assessment Scales in Depression and Anxiety. London and New York: Taylor & Francis, 2005.Google Scholar
  5. 5.
    Meltzer-Brody S, Davidson JR. Completeness of response and quality of life in mood and anxiety disorders. Depress Anxiety 2000; 12(Suppl 1):95–101.PubMedCrossRefGoogle Scholar
  6. 6.
    Guess HA, Kleinman A, Kusek JW, et al (eds). The Science of the Placebo: Towards an interdisciplinarly research agenda. London: BMJ Books, 2002.Google Scholar
  7. 7.
    Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002; 287:1840–1847.PubMedCrossRefGoogle Scholar
  8. 8.
    Angst J, Scheidegger P, Stabl M. Efficacy of moclobemide in different patient groups. Results of new subscales of the Hamilton Depression Rating Scale. Clin Neuropharmacol 1993; 16(Suppl 2):S55–S62.PubMedGoogle Scholar
  9. 9.
    Barrett JE, Williams JW Jr, Oxman TE, et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001; 50: 405–441.PubMedGoogle Scholar
  10. 10.
    Anderson I, Ferrier I, Baldwin R, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22:343–396.PubMedCrossRefGoogle Scholar
  11. 11.
    Posternak MA, Solomon DA, Leon AC, et al. The naturalistic course of unipolar major depression in the absence of somatic therapy. J Nerv Ment Dis 2006; 194: 324–329.PubMedCrossRefGoogle Scholar
  12. 12.
    Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297:1683–1696.PubMedCrossRefGoogle Scholar
  13. 13.
    Lotrich F, Pollack B. Aging and clinical pharmacology: Implications for antidepressants. J Clin Pharmacol 2005; 45:1106–1122.PubMedCrossRefGoogle Scholar
  14. 14.
    Food and Drug Administration. Clinical Review: Relationship between antidepressant drugs and suicidality in adults. Department of Health and Human Service, FDA, Center for Drug Evaluation and Research, 2006; 130:1.Google Scholar
  15. 15.
    Dombrovski A, Lentze E, Dew M, et al. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized controlled trial of paroxetine and interpersonal therapy. J Am Geriatric Soc 2007; 55:1325–1332.CrossRefGoogle Scholar
  16. 16.
    Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 2006; 59:1029–1038.PubMedCrossRefGoogle Scholar
  17. 17.
    Gensichen J, Beyer M, Muth C. Case management to improve major depression in primary health care: a systematic review. Psychol Med 2006; 36: 7–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 2004; 61: 669–680.PubMedCrossRefGoogle Scholar
  19. 19.
    National Institute for Health and Clinical Excellence. Depression: the treatment and management of depression in adults. Clinical guideline 90, London: NICE, 2009. Accessible at
  20. 20.
    Meyers BS, Sirey JA, Bruce M, et al. Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study. Arch Gen Psychiatry 2002; 59:729–735.PubMedCrossRefGoogle Scholar
  21. 21.
    Ezquiaga E, Garcia A, Bravo F, et al. Factors associated with outcome in major depression: a 6-month prospective study. Soc Psychiatry Psychiatr Epidemiol 1998; 33:552–557.PubMedCrossRefGoogle Scholar
  22. 22.
    Bagby RM, Ryder AG, Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci 2002; 27:250–257.PubMedGoogle Scholar
  23. 23.
    Okiishi JC, Lambert ML, Eggett E, et al. An analysis of therapist treatment effects: toward providing feedback to individual therapists on their clients’ psychotherapy outcome. J Clin Psychol 2006; 62:1157–1172.PubMedCrossRefGoogle Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  1. 1.Neuroscience and Psychiatry Unit Mental Health and Neurodegeneration Research Group, School of MedicineUniversity of ManchesterManchesterUK

Personalised recommendations